PTC THERAPEUTICS, INC.
PTCT
DELAYED 1 MONTH
9 insider filings · Latest: Jul 28, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | May 19 9:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Sale | 2,812 | $72.18 | $203.0K | 105,212(D) | View → |
| May 14, 2026 | May 15 9:20 PM | Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICER | Sale | 12,572 | $72.95 | $917.2K | 393,998(D) | View → |
| May 8, 2026 | May 12 9:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Sale | 3,540 | $78.97 | $279.6K | 105,212(D) | View → |
| Mar 12, 2026 | Mar 13 9:20 PM | Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICER | Sale | 2,662 | $64.08 | $170.6K | 396,920(D) | View → |
| Mar 10, 2026 | Mar 12 9:20 PM | Stephanie OkeyDirector | Sale | 15,167 | $70.00 | $1.1M | 8,000(D) | View → |
| Mar 5, 2026 | Mar 9 9:20 PM | Stephanie OkeyDirector | Sale | 6,333 | $63.38 | $401.4K | 8,000(D) | View → |
| Mar 5, 2026 | Mar 9 9:20 PM | Lee Scott GoldenEVP & CHIEF MEDICAL OFFICER | Sale | 10,000 | $63.38 | $633.8K | 79,944(D) | View → |
| Mar 5, 2026 | Mar 9 9:20 PM | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | Sale | 3,989 | $63.38 | $252.8K | 2,737(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | Jul 31 1:02 AM | Hege Elisabeth Sollie-ZetlmayerDirector | Grant/Award | 5,213 | $75.39 | 1,738(D) | View → |
| May 15, 2026 | May 19 9:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Option Exercise | 2,812 | $25.69 | 19,689(D) | View → |
| May 8, 2026 | May 12 9:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Option Exercise | 3,540 | $46.54 | 41,460(D) | View → |
| Mar 10, 2026 | Mar 12 9:20 PM | Stephanie OkeyDirector | Option Exercise | 15,167 | $33.63 | 0(D) | View → |